6505--PET MRI Radiopharmaceuticals - Notice of Intent to Sole Source
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C25025Q0891
- Agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, has published a Special Notice of Intent to Sole Source for PET MRI Radiopharmaceuticals. The procurement is intended for the John D. Dingell VA Medical Center in Detroit, Michigan, covering four specific radiopharmaceutical products used in Nuclear Medicine for PET MRI patient examinations. The VA intends to award a sole source, firm-fixed price, one-year purchase order to Sofie Co., located in Dulles, Virginia. The contract falls under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing) with a business size standard of 1,300 employees. The procurement covers the period from October 1, 2025, through September 30, 2026, and includes Cu-64 Dotatate, F18 PSMA, F18 Fluorodeoxyglucose, and F18 Neuraceq in specified quantities.
The purpose of this sole source procurement is to provide essential radiopharmaceutical supplies for nuclear medicine procedures at the Detroit VA Medical Center. The VA previously conducted a sources sought notice from August 18-22, 2025, which received responses from five contractors, but determined that Sofie Co. is the only vendor capable of providing all required radiopharmaceuticals. Interested parties may submit capability statements demonstrating competitive advantage to Contracting Officer Jeffrey Rozema by 5:00 PM Eastern Time on September 2, 2025. The contractor must provide all products including packaging, transportation, manifests, and reports as part of the service delivery. This notice satisfies the FAR 5.201(b)(1) requirement to publicize the proposed contract action and is not a request for competitive proposals or quotes.
Notice text
INTENT TO SOLE SOURCE
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees.
The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2025, through September 30, 2026. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients.
Product Name
UoM
Est. Annual Quantity
Cu-64 Dotatate (Detectnet) 3-5 mCi
Dose
25
F18 PSMA (Pylarify) 8-10 mCi
Dose
70
F18 Fluorodeoxyglucose (FDG) 8-10 mCi
Dose
908
F18 Neuraceq 8-10 mCi
Dose
52
It is the Government s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25025Q0852 was published on Contract Opportunities from August 18, 2025 through August 22, 2025. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine.
This notice satisfies the requirement at FAR 5.201(b)(1) to publicize the proposed contract action. This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Interested persons may identify their interests and capability to respond to this requirement no later than 5:00 PM Eastern Time, Tuesday, September 2, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.
Interest/capability statements shall be submitted to Jeffrey Rozema, Contracting Officer, via e-mail at jeffrey.rozema@va.gov. Telephone inquiries will not be accepted.
Files
| File | Type | Posted |
|---|---|---|
| 36C25025Q0891.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--PET MRI Radiopharmaceuticals | Limited / Sole Source Justification | |
| 6505--PET MRI Radiopharmaceuticals | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity